Page last updated: 2024-08-25

4-phenylbutylamine and ALS - Amyotrophic Lateral Sclerosis

4-phenylbutylamine has been researched along with ALS - Amyotrophic Lateral Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alfahel, L; Ali Saleh, M; Argueti-Ostrovsky, S; Azoulay-Ginsburg, S; Barel, S; Ebbinghaus, S; Gruzman, A; Israelson, A; Kahn, J; Rothstein, A	1

Other Studies

1 other study(ies) available for 4-phenylbutylamine and ALS - Amyotrophic Lateral Sclerosis

Article	Year
4-Phenylbutyric Acid (4-PBA) Derivatives Prevent SOD1 Amyloid Aggregation In Vitro with No Effect on Disease Progression in SOD1-ALS Mice. International journal of molecular sciences, 2022, Aug-20, Volume: 23, Issue:16 Topics: Amyloid; Amyloidogenic Proteins; Amyotrophic Lateral Sclerosis; Animals; Butylamines; Disease Models, Animal; Disease Progression; Mice; Mice, Transgenic; Molecular Chaperones; Neurodegenerative Diseases; Phenylbutyrates; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1	2022

Article

Year

4-Phenylbutyric Acid (4-PBA) Derivatives Prevent SOD1 Amyloid Aggregation In Vitro with No Effect on Disease Progression in SOD1-ALS Mice.

International journal of molecular sciences, 2022, Aug-20, Volume: 23, Issue:16

Topics: Amyloid; Amyloidogenic Proteins; Amyotrophic Lateral Sclerosis; Animals; Butylamines; Disease Models, Animal; Disease Progression; Mice; Mice, Transgenic; Molecular Chaperones; Neurodegenerative Diseases; Phenylbutyrates; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1

2022